{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMGY-ooJDA","lastupdate":"2024-03-21T00:00:00.000Z","update_date":"2024-03-21T00:00:00.000Z","lastModified":"Sep 23, 2025","active":1,"confidence_score":89,"confidence_score_reason":"video or image, markets, not claimed","urlname":"restore-medical","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$Aad6YNue0Dd8CQs0rgkPCuWDrIR0HCnGIn8der0JAfW42nsN5LNgc2","name":"Restore Medical","oneliner":"Catheter-delivered Implant for Congestive Heart Failure","registrar":"515166346","website":"https://restoremedical.co/","careerspage":"","founded_month":2,"founded_year":2015,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/30659944","instagram":""},"social":["https://www.linkedin.com/company/30659944"],"flattenedsociallinks":"https://www.linkedin.com/company/30659944","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":14,"patent":1,"raised":29430000,"stage":"B","public_stage":"B","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Restore Medical is dedicated to improve the treatment of congestive heart failure (CHF) by developing innovative and disruptive medical device that will reduce hospitalizations, mortality, and morbidity. The company has developed the first and only transcatheter Pulmonary Artery Banding  (PAB) system for the treatment of HFrEF patients.\n\nContraBand is an innovative and reversible therapy for the treatment of left ventricle (LV) failure. The catheter-delivered implant is designed to leverage the right ventricle (RV) to provide support to the LV, improving LV ejection fraction and restoring optimal ventricular geometry. With no approved treatments currently available for this condition, ContraBand has the potential to transform the way congestive heart failure (CHF) patients are treated.\n\nOngoing Clinical trial have demonstrated that ContraBand is a highly effective and safe treatment for patients with LV failure. The implantation procedure for ContraBand is simple and time effective. \n\n","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972765303888","country":null,"address":{"israeli":[{"id":"5212f64e-1ccd-49fb-aad9-01a287b632cd","city":"Or Yehuda","type":null,"address":"Yehonatan Netanyahu Street 6, Or Yehuda, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"s3LLfzA0K071ruwMEgZXqVncFxBOXnHbHr3Ho7H0YxjfMovChKuXX6","date":"Jul 13, 2025","link":"https://www.globes.co.il/news/article.aspx?did=1001515620","source":"www.globes.co.il","visible":1,"analysis":{"tags":"fertility startup","round":null,"company":"ERA","layoffs":null,"summary":"Omri Shtaywi, brother of a kidnapped and murdered individual, has founded a fertility startup named ERA. The startup aims to create life in response to the loss of his brother. ERA has developed a language model tailored for the fertility sector, aiming to streamline the complex processes involved in fertility treatments. The company has raised an initial funding of $500,000 from investors including Fusion, Avishai Abrahami, Omer Kaplan, and Eynat Guez. The startup is in the R&D stage and plans to expand in the US. The business model involves a community with B2B2C elements, offering a freemium model to consumers and connecting them with service providers.","partners":["Dr. Ofer Fainaru"],"customers":null,"eventType":null,"investors":["Fusion","Avishai Abrahami","Omer Kaplan","Eynat Guez"],"confidence":9,"key_topics":["fertility","AI technology","investment","IVF","partnerships"],"date_of_event":"October 2024","product_stage":"R&D","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"500,000","structured_issues":["Investment","Product Stage","Partners"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Investment  #Product Stage  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"UDXQ4IiFsyWxuJUV6Dx81yUvye0P8b7Ytv2xXEQCk4BmmVB9YBZnqJ","news_summary":"ראיון עם אחיו של החטוף עידן שתיוי שנרצח ב-7 באוקטובר, מקים סטארט-אפ בתחום הפוריות ● הבדל בין גברים ונשים בעיכול חלבונים ● ביולייט הודיעה על השלמת ניסוי קליני בו הראתה שהיא מצליחה לאבחן ניוון ראייה בנוזל דמעות ● גיוס של 23 מיליון דולר ל-Restore Medical בתחום אי ספיקת הלב ● אישור FDA לטכנולוגיה של Synchrony Medical לניקוי דרכי הנשימה ● השבוע בביומד ","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"n2tLUSeS9eGohEFinY1vIylOOTU3rgFf49IqYpil0q2DGThbxRISGJ","date":"Jul 7, 2025","link":"https://www.geektime.co.il/restore-medical-nabs-21m-to-treat-heart-failure/","source":"www.geektime.co.il","visible":1,"analysis":null,"sentiment":null,"analysisId":"FnFDliHnnRpS5vEYrvUVkTOYUqdglEU5AUC34WeH2rb93jg0PX8SMI","news_summary":"Israeli startup Restore Medical raises $23 million to treat heart failure and has already begun clinical trials\n","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"vo3ZAnuNP9rfVLL4wQw28EbD58WJsZTo9lNJ0eX1n0VJ91EUfxlsT7","date":"Jul 18, 2024","link":"https://www.prnewswire.com/news-releases/restore-medical-receives-breakthrough-device-designation-from-fda-for-contraband-system-to-treat-hfref-patients-302200547.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"FDA approval","company":"Restore Medical","layoffs":null,"summary":"Restore Medical, a leader in interventional cardiology, has received Breakthrough Device Designation from the FDA for its ContraBand™ device, aimed at treating heart failure with reduced ejection fraction (HFrEF). This designation is a significant milestone, highlighting the devices potential to address unmet needs in cardiac care. The ContraBand™ is a minimally invasive transcatheter Pulmonary Artery Banding system designed to improve the quality of life for HFrEF patients. The FDAs decision was based on promising results from an ongoing feasibility study. Restore Medical is backed by investors including Peregrine Ventures and the European Innovation Council, reflecting strong support for its innovative technology.","partners":null,"customers":null,"investors":["Peregrine Ventures","European Innovation Council","undisclosed strategic investor"],"confidence":10,"key_topics":["FDA approval","heart failure","medical device","innovation","cardiology"],"date_of_event":"Not explicitly mentioned","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xrm8952J4rXGWasg3tJL1NRptZ308Dx4Qw9EbEWqREtPB70O1qPVUH","news_summary":"Restore Medical Receives Breakthrough Device Designation from FDA for ContraBand™ System to Treat HFrEF Patients","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"QXVEa4vvb2XzdX1O1JULfPUK3kO5eW0rr4LfcY1fS1rsP0Q1Bpd5e2","date":"Mar 7, 2023","link":"https://www.prnewswire.com/news-releases/restore-medical-announces-successful-first-in-human-preliminary-results-of-its-contraband-system-for-symptomatic-systolic-heart-failure-patients-301764647.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Medical Device, Clinical Study","company":"Restore Medical Ltd","layoffs":"Not mentioned","summary":"Restore Medical Ltd, a medical device company, has completed enrollment for its First In Human clinical study with its CONTRABAND device. The device is a Pulmonary Artery Banding (PAB) transcatheter implant designed to treat heart failure with reduced ejection fraction (HFrEF) and improve the quality of life for heart failure patients. The study enrolled 15 patients across 5 European hospitals, all of whom experienced symptom improvement. The CONTRABAND device improved the quality of life of the treated patients and led to a reduction in the New York Heart Association (NYHA) heart class and improvement of left ventricle ejection fraction (LVEF).","partners":"Not mentioned","customers":"15 patients","investors":"Peregrine Ventures, Horizon Europe, undisclosed strategic investor","confidence":9,"key_topics":"Clinical Study, Heart Failure Treatment, CONTRABAND Device, Patient Improvement, Investment","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Investment, Customers","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment, Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"tsZvPvqc7NMnG42kZl6RlBvLk4AjLAG5BgdLB35hP4pfHnVIC4xtil","news_summary":"Restore Medical Announces Successful First-In-Human Preliminary Results of Its CONTRABAND™ System for Symptomatic Systolic Heart Failure Patients","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"fe0efd2c-e9e2-4aa7-b318-7667c2bcf374","date":"Jun 28, 2022","link":"https://www.calcalist.co.il/ctechnews/article/rjejifvqq","source":"www.calcalist.co.il","visible":1,"analysis":{"tags":"medical technology","company":"Restore Medical","layoffs":null,"summary":"Restore Medical has been awarded a €2.5 million grant and a potential €10 million equity investment from the European Innovation Council (EIC) to support the development of its cardiac implants for the treatment of congestive heart failure. The company is running a First in Human clinical study in Europe with promising results. Restore Medical was one of the 74 winning companies selected out of 1,093 applicants for EIC funding. Congestive heart failure is a leading cause of mortality and hospital readmissions, affecting millions of people worldwide. Restore Medical was established in 2015 and is led by CEO Gilad Marom.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["clinical-stage medtech","cardiac implants","congestive heart failure","EIC funding","clinical development"],"date_of_event":"March 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"€2.5 million grant and potential €10 million equity investment","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pZ5sk3GYGnXJHgzRRFkVpKTaYtZUZkfWtN6cK7R7KECJwI8QGqk0Eu","news_summary":"Restore Medical secures €2.5 million in EU funding for cardiac implants to treat heart failure  CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"264e31c0-590e-4760-bac1-075d3e5ae1ae","date":"Jan 16, 2022","link":"https://www.israel21c.org/revolutionary-implant-could-ease-congestive-heart-failure/","source":"www.israel21c.org","visible":1,"analysis":{"tags":["medical technology","congestive heart failure","implantable device"],"company":"Restore Medical","layoffs":null,"summary":"Israeli startup Restore Medical has developed an implantable device called ContraBand to treat congestive heart failure (CHF). CHF affects millions of people globally and is a leading cause of mortality. The ContraBand implant is inserted into the pulmonary artery and supports the failed left ventricle by changing the pressure on the healthy right ventricle. The implant is not a cure for CHF but can reduce symptoms and hospitalizations. Restore Medical has conducted trials on animals and treated three human patients. The company plans to recruit more patients for clinical trials to seek regulatory approval. The CEO hopes to have a commercialized version of ContraBand available by 2026. The devices functionality is reversible, which is rare in the cardio implant world. Restore Medical has raised at least $1 million in funding.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Congestive heart failure","Implantable device","Clinical trials","FDA approval","Reversible functionality"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9lVp3705dI8p2YOoRb4DxNUZRCAQ6c79Qkz6RQc0cIDWQqMQZMM3Bm","news_summary":"Revolutionary implant could ease congestive heart failure","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b008aa05-a4c9-4054-b6ae-74c6662a3173","date":"Dec 23, 2021","link":"https://en.globes.co.il/en/article-restore-medical-successfully-implants-heart-failure-device-1001395877","source":"en.globes.co.il","visible":1,"analysis":{"tags":"medical technology","company":"Restore Medical","layoffs":null,"summary":"Israeli company Restore Medical has successfully implanted its product, ContraBand, in human patients for the first time. ContraBand is designed to treat heart congestion and is implanted using a minimally invasive procedure. The product aims to assist the failing left ventricle in patients with chronic left ventricular failure. Congestive heart failure is a progressive and debilitating disease, and Restore Medicals treatment has the potential to improve the quality of life for patients and reduce financial burdens. The company was established in 2015 and is backed by investors including Incentive Incubator, Peregrine Ventures, Allegro, and an undisclosed strategic investor.","partners":null,"customers":null,"investors":"Incentive Incubator, Peregrine Ventures, Allegro","confidence":9,"key_topics":["Congestive heart failure","Clinical trial","Implantable device","Minimally invasive procedure","Chronic left ventricular failure"],"date_of_event":"2021-12-23","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"8L50ZFP2Iqh8BBbGgRJeapA0Mh2qRdtL6LnDdj3bIXvvJXrH1TIKB9","news_summary":"Restore Medical successfully implants heart failure device","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8337598e-7104-46f3-8c81-da47cdd83c52","date":"Dec 7, 2021","link":"https://www.prnewswire.com/news-releases/restore-medical-announces-first-in-human-trial-for-treatment-of-heart-failure-in-patients-301438723.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"clinical trial, cardiac implants, congestive heart failure","company":"Restore Medical Ltd.","layoffs":null,"summary":"Restore Medical Ltd. announced promising preliminary results of the First-in-Human clinical trial of ContraBand™, a breakthrough treatment for patients suffering from congestive heart failure (CHF). The company successfully implanted the ContraBand™ in its first patients and the treatment is expected to relieve symptoms and improve patients quality of life. CHF affects millions of people worldwide and is considered a significant unmet clinical and financial need. Restore Medical Ltd. was established in 2015 and has developed a novel technology to improve the quality of life for patients with failing hearts.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["ContraBand™","clinical trial","cardiac implants","congestive heart failure","CHF"],"date_of_event":"2021-12-07","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"72mbYihEkaM0Re3fhasspGJS6NtL1cVbt3isS2wh04jBWv2G4CUexh","news_summary":"Restore Medical Announces First in Human Trial for Treatment of Heart Failure in Patients","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":8,"techcommunityinvolvement":null,"mediagallery":[],"tags":["catheters","hospitals","medical-devices","cardiology","heart-failure"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["ContraBand"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":3,"lastfunding":"$23M","totalrounds":5,"fundingstage":"B","totalfunding":"$29.43M","publicinvestors":3,"lastpublicfunding":23000000,"totalpublicrounds":5,"totalpublicfunding":29430000},"team":[{"name":"Gilad Marom","email":"gilad@restoremedical.co","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4NLgtIoKDA","bounced":false,"claimed":0,"founder":0,"urlname":"gilad-marom","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgzorfmwsM","position":"CEO","last_name":"Marom","claimtoken":"9KJS9do7oXJ31GR3wZ1rsoUaiGwv2uolizcR4QWbGwro5TWRWtukyO","first_name":"Gilad","picturekey":"$dbLVnPn3WzV3AVTaZMG9PnruvfGo4YJpz4I8aAUPZRfdcIT9wMDxWF","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/gilad-marom-136a881/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-21 15:33:59.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$dbLVnPn3WzV3AVTaZMG9PnruvfGo4YJpz4I8aAUPZRfdcIT9wMDxWF","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Elchanan  Bruckheimer","email":"elchanan@restoremedical.co","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNmws-wLDA","bounced":true,"claimed":0,"founder":1,"urlname":"elchanan-bruckheimer","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg2ZKYzAoM","position":"Co-founder & CMO","last_name":"Bruckheimer","claimtoken":"7H0jBv9E9j7tt7aZ4PAaaVIMIoW7Fjw7xWWjmKTjwS5mSya6o4wgDm","first_name":"Elchanan ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/elchanan-bruckheimer-22839b8/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-21 15:34:01.000000","initials":"EB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Stephen Bellomo","email":"stephen@restoremedical.co","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwIGJioYKDA","bounced":false,"claimed":0,"founder":1,"urlname":"stephen-bellomo","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDAgYmKhgkM","position":"Co-founder & VP Clinical Afffairs","last_name":"Bellomo","claimtoken":"F2PHXIm2HSDUfatQ2dSTcJV7ouAXaYkKfhpnikh0v3z3AXVITOzN7I","first_name":"Stephen","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/stephen-bellomo-7a412a21/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-03-21 15:34:03.000000","initials":"SB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-04-06T00:00:00.000Z","crunchbaseid":"restore-medical-ltd","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jenny Sotnik-Talisman","creator_email":"genys30@yahoo.com","createdate":"2016-11-15T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"FOkOcpX8bFEFRwfU9aBf5x22ABrZm0tFfBSzXAHlpMfCFDsF8hZ4Uo","date":"Jul 2025","amount":"$23M","source":"https://www.calcalistech.com/ctechnews/article/sjgxx11fhxl","eventtype":"FundingRoundEvent","investment":[{"name":"Pitango HealthTech","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/pitango-healthtech","logokey":"$F6Cygr894cajpFfKzw59bltMwYAzg7zweRSQNoLbPYayCsjiVjowFM","tagline":null,"urlname":"/investor_page/pitango-healthtech","isisraeli":1,"investorid":"0WDapIjwQhWsxJicr6lGBbSzAQKMumCfRAiMpVUb497i0CiI1Xuiej","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"C1PIG4LMe1VydU2rEPu5SSuOxxDlqJgfEJTYwHuGa2RuPPLrBosTHx","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$F6Cygr894cajpFfKzw59bltMwYAzg7zweRSQNoLbPYayCsjiVjowFM","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"Peregrine Ventures","type":"Investor","amount":1300000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"LaXLV1tSOYddBatZsaiTET2wwC16qYQtaVF1Ddl9rq40ZYtPTXQqRl","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "},{"name":"European Union’s EIC Fund","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/european-union-s-eic-fund","logokey":"$YQ0gYHbpMvoHMJK34CJyZLAnMytLrGyCRJXaSFKy48bQ3iBkItVyxf.jpeg","tagline":"Venture investment arm of the European Innovation Council (EIC)","urlname":"/investor_page/european-union-s-eic-fund","isisraeli":null,"investorid":"gM7CnZw0FHNRRtctbPzcqLZCnyeov2vhQ7YjNEaQIno94hVdbTkGeQ","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"cEPNaQMGojEAGZcqLG7FBFdxxjRX5aJMawktaeH4CwLvwXabNcj0Yl","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YQ0gYHbpMvoHMJK34CJyZLAnMytLrGyCRJXaSFKy48bQ3iBkItVyxf.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":23000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"Sf9k1jsq777O9osmAG0olyFgIzuWhe1mAqgD6cAoWDAvmBOhpJbF8k","date":"Mar 2023","amount":"$1.33M","source":"Amit from Peregrine","eventtype":"FundingRoundEvent","investment":[{"name":"Peregrine Ventures","type":"Investor","amount":1330000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"lwheRdt4akr4aN7haBVSVnzhUKK1QVrcP6AGNVSDlqE2Q6AGz46sie","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1330000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCCie7XCQw","date":"Jun 2022","amount":"$2.6M","source":"https://www.calcalist.co.il/ctechnews/article/rjejifvqq","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"European Innovation Council (EIC)","type":"Other","amount":2600000,"hidden":false,"country":"Unknown location","fullurl":"/company_page/european-innovation-council-eic","logokey":null,"tagline":"European Innovation Council (EIC) ","urlname":"/company_page/european-innovation-council-eic","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODKhviGCQw","fundingtype":"Other","leadpartner":null,"investmentid":"572664aa-edf0-4250-9e65-43c3d469be98","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":2600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"E6lbQYdJZBeUCXW6dt9lOk6bLCTcw0QX2RwhhSxmGmkeY3gZPH3NHv","date":"Mar 2022","amount":"$1.5M","source":"Amit from Peregrine","eventtype":"FundingRoundEvent","investment":[{"name":"Peregrine Ventures","type":"Investor","amount":1500000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"7hRQu5zXjcmhW46JvPzfsf3TN8M4GFidPSHUcFS16SXtG9H81hf4cx","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCglbO-CAw","date":"Mar 2020","amount":"$1M","source":"Crunchbase, Rasham","eventtype":"FundingRoundEvent","investment":[{"name":"Peregrine Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"enV3CgItMABPqoqRKM3mx9sNUMiLzxSVCKveqCiSflnDSYqOVPwsIc","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"2/2015","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Restore Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$Aad6YNue0Dd8CQs0rgkPCuWDrIR0HCnGIn8der0JAfW42nsN5LNgc2","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$Aad6YNue0Dd8CQs0rgkPCuWDrIR0HCnGIn8der0JAfW42nsN5LNgc2","seoabout":"Restore Medical is dedicated to improve the treatment of congestive heart failure (CHF) by developing innovative and disruptive medical device that will re...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Implants","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Implants#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Implants#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances","children":[{"title":"Implants","key":"0-0-0","path":"TechnologyClassificationModel>Materials & Substances>Implants"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Implants","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Materials & Substances","Implants"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"FOkOcpX8bFEFRwfU9aBf5x22ABrZm0tFfBSzXAHlpMfCFDsF8hZ4Uo","date":"Jul 2025","amount":"$23M","source":"https://www.calcalistech.com/ctechnews/article/sjgxx11fhxl","eventtype":"FundingRoundEvent","investment":[{"name":"Pitango HealthTech","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/pitango-healthtech","logokey":"$F6Cygr894cajpFfKzw59bltMwYAzg7zweRSQNoLbPYayCsjiVjowFM","tagline":null,"urlname":"/investor_page/pitango-healthtech","isisraeli":1,"investorid":"0WDapIjwQhWsxJicr6lGBbSzAQKMumCfRAiMpVUb497i0CiI1Xuiej","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"C1PIG4LMe1VydU2rEPu5SSuOxxDlqJgfEJTYwHuGa2RuPPLrBosTHx","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$F6Cygr894cajpFfKzw59bltMwYAzg7zweRSQNoLbPYayCsjiVjowFM","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"Peregrine Ventures","type":"Investor","amount":1300000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"LaXLV1tSOYddBatZsaiTET2wwC16qYQtaVF1Ddl9rq40ZYtPTXQqRl","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "},{"name":"European Union’s EIC Fund","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/european-union-s-eic-fund","logokey":"$YQ0gYHbpMvoHMJK34CJyZLAnMytLrGyCRJXaSFKy48bQ3iBkItVyxf.jpeg","tagline":"Venture investment arm of the European Innovation Council (EIC)","urlname":"/investor_page/european-union-s-eic-fund","isisraeli":null,"investorid":"gM7CnZw0FHNRRtctbPzcqLZCnyeov2vhQ7YjNEaQIno94hVdbTkGeQ","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"cEPNaQMGojEAGZcqLG7FBFdxxjRX5aJMawktaeH4CwLvwXabNcj0Yl","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YQ0gYHbpMvoHMJK34CJyZLAnMytLrGyCRJXaSFKy48bQ3iBkItVyxf.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":23000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"Sf9k1jsq777O9osmAG0olyFgIzuWhe1mAqgD6cAoWDAvmBOhpJbF8k","date":"Mar 2023","amount":"$1.33M","source":"Amit from Peregrine","eventtype":"FundingRoundEvent","investment":[{"name":"Peregrine Ventures","type":"Investor","amount":1330000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"lwheRdt4akr4aN7haBVSVnzhUKK1QVrcP6AGNVSDlqE2Q6AGz46sie","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1330000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"E6lbQYdJZBeUCXW6dt9lOk6bLCTcw0QX2RwhhSxmGmkeY3gZPH3NHv","date":"Mar 2022","amount":"$1.5M","source":"Amit from Peregrine","eventtype":"FundingRoundEvent","investment":[{"name":"Peregrine Ventures","type":"Investor","amount":1500000,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"7hRQu5zXjcmhW46JvPzfsf3TN8M4GFidPSHUcFS16SXtG9H81hf4cx","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCglbO-CAw","date":"Mar 2020","amount":"$1M","source":"Crunchbase, Rasham","eventtype":"FundingRoundEvent","investment":[{"name":"Peregrine Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/peregrine-ventures","logokey":"$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","tagline":null,"urlname":"/investor_page/peregrine-ventures","isisraeli":1,"investorid":"Y57DaSxuoKU94wasDhLnfv7mvfy2Gyr9ekuOlM6BCGtWak5CprFY2M","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"enV3CgItMABPqoqRKM3mx9sNUMiLzxSVCKveqCiSflnDSYqOVPwsIc","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9b3MhmeKbyWXOhmHsdeo59IpRH5j3rFLwfog4x6rVvePI0vqruN3t","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCCie7XCQw","date":"Jun 2022","amount":"$2.6M","source":"https://www.calcalist.co.il/ctechnews/article/rjejifvqq","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"European Innovation Council (EIC)","type":"Other","amount":2600000,"hidden":false,"country":"Unknown location","fullurl":"/company_page/european-innovation-council-eic","logokey":null,"tagline":"European Innovation Council (EIC) ","urlname":"/company_page/european-innovation-council-eic","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODKhviGCQw","fundingtype":"Other","leadpartner":null,"investmentid":"572664aa-edf0-4250-9e65-43c3d469be98","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":2600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}